Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

NCT03794778 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

396

Enrollment

OTHER

Sponsor class

Conditions

Efficacy and Safety

Interventions

DRUG: pegylated liposomal doxorubicin
DRUG: paclitaxel
DRUG: Carboplatin

Sponsor

Women's Hospital School Of Medicine Zhejiang University